BIOTRICITY INC (BTCY)

US09074H2031 - Common Stock

1.17  +0.05 (+4.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
3.38M
138.03%		7.65M
126.33%		9.64M
26.01%		12.24M
26.97%
EBITDA
YoY % growth
N/AN/A-13.61M-15.471M
-13.67%		N/A
EBIT
YoY % growth
-12.87M
-17.75%		-17.47M
-35.74%		-13.62M
22.04%		-8.772M
35.59%
Operating Margin
-380.77%-228.37%-141.29%-71.67%
EPS
YoY % growth
N/A-1.61-2.24
-39.38%		-1.58
29.55%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.37
32.00%
Revenue
Q2Q % growth		3.264M
19.12%
EBITDA
Q2Q % growth		-2.808M
EBIT
Q2Q % growth		-2.04M
-23.64%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.34
37.22%		-0.450.1124.47%
Q2 2024
Q2Q % growth		 -0.44
21.81%		-0.35-0.09-27.16%
Q1 2024
Q2Q % growth		 -0.41
31.67%		-0.420.011.96%
Q4 2023
Q2Q % growth		 -0.54
18.18%		-0.550.011.96%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 2.973M
20.85%		3.06M-87.03K-2.84%
Q2 2024
Q2Q % growth		 2.89M
21.43%		3.366M-476K-14.14%
Q1 2024
Q2Q % growth		 3.02M
46.60%		3.162M-142K-4.49%
Q4 2023
Q2Q % growth		 2.74M
27.44%		2.652M88K3.32%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 16.28% 0% 10.4%
Revenue0% 0% 0% -0.91%